Welcome to our dedicated page for GeoVax Labs New news (Ticker: GOVX), a resource for investors and traders seeking the latest updates and insights on GeoVax Labs New stock.
GeoVax Labs, Inc. (Nasdaq: GOVX) is a clinical-stage biotechnology company specializing in the development of human vaccines and immunotherapies against infectious diseases and cancers. Utilizing their innovative Modified Vaccinia Ankara-Virus-Like Particle (MVA-VLP) platform, GeoVax has a strong focus on creating vaccines that stimulate both humoral and cellular immune responses to various targeted infections.
GeoVax's product pipeline includes an advanced Covid-19 vaccine, GEO-CM04S1, which is currently undergoing three phase 2 clinical trials. This next-generation vaccine is designed to induce robust antibody and T-cell responses against multiple SARS-CoV-2 variants, including Delta and Omicron. GEO-CM04S1 is especially targeted at high-risk immunocompromised populations who may not respond adequately to existing vaccines.
In oncology, GeoVax is pioneering novel therapies with Gedeptin®, an oncolytic gene-directed therapy for solid tumors. Gedeptin® is in phase 1/2 clinical trials for advanced head and neck cancers, aiming to provide new treatment avenues for patients with limited options.
GeoVax has shown significant progress in vaccine development against other infectious diseases such as Mpox, smallpox, HIV, Zika, hemorrhagic fever viruses, and malaria. Their recent partnership with the National Institute of Allergy and Infectious Diseases (NIAID) has expanded their vaccine development license to include Mpox and smallpox, leveraging their MVA technology for broader immunological protection.
The company also focuses on intellectual property, holding over 115 granted or pending patents across 24 patent families. This robust IP portfolio enhances their competitive edge in the biopharmaceutical sector.
GeoVax's commitment to innovative research and scalable manufacturing solutions positions them as a key player in the fight against some of the world’s most threatening diseases. For more detailed information, visit their official website at www.geovax.com.
FAQ
What is the current stock price of GeoVax Labs New (GOVX)?
What is the market cap of GeoVax Labs New (GOVX)?
What is GeoVax Labs, Inc.?
What is the MVA-VLP platform?
What are the main products in GeoVax’s pipeline?
What is the current status of the GEO-CM04S1 vaccine?
What is Gedeptin®?
How does GeoVax’s partnership with NIAID benefit their technology?
What recent achievements has GeoVax announced?
How extensive is GeoVax’s intellectual property portfolio?
What is the significance of GeoVax’s Covid-19 vaccine?
How can I learn more about GeoVax Labs, Inc.?
